DIA
SUPN icon

Dana Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Dana Investment Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-46,749
Closed -$2.8M – 284
2018
Q2 		$2.8M Sell
46,749
-9,857
-17% -$511K 0.12% 125
2018
Q1 		$2.59M Sell
56,606
-798
-1% -$33.3K 0.12% 129
2017
Q4 		$2.29M Sell
57,404
-662
-1% -$26.2K 0.1% 162
2017
Q3 		$2.32M Sell
58,066
-101
-0.2% -$4.37K 0.11% 161
2017
Q2 		$2.51M Sell
58,167
-22,864
-28% -$814K 0.12% 142
2017
Q1 		$2.54M Sell
81,031
-7,047
-8% -$189K 0.12% 142
2016
Q4 		$2.22M Sell
88,078
-946
-1% -$21.1K 0.1% 169
2016
Q3 		$2.2M Sell
89,024
-15,233
-15% -$345K 0.11% 139
2016
Q2 		$2.12M Buy
104,257
+16,912
+19% +$300K 0.09% 160
2016
Q1 		$1.33M Buy
+87,345
New +$1.14M 0.06% 180

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Dana Investment Advisors's SUPN Position: Q3 2018 in Review

Dana Investment Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q3 2018, closing a stake of 46,749 shares — an estimated $2.8M sold.

Dana Investment Advisors first reported a position in SUPN in Q1 2016 and held it in 10 quarters. The position peaked at $2.8M in Q2 2018. 288 funds tracked by Wall St. Rank hold SUPN as of Q3 2018.

  • Dana Investment Advisors reported no remaining Supernus Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Dana Investment Advisors sold 46,749 Supernus Pharmaceuticals shares in Q3 2018, an estimated $2.8M.
  • Dana Investment Advisors first reported a position in Supernus Pharmaceuticals in Q1 2016 and held it in 10 quarters.
  • Dana Investment Advisors's Supernus Pharmaceuticals position peaked at $2.8M in Q2 2018.
  • 288 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2018.

Based on Dana Investment Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.